LifeVantage to Participate in the 28th Annual ICR Conference
Rhea-AI Summary
LifeVantage (Nasdaq: LFVN) will participate in the 28th Annual ICR Conference in Orlando, FL, January 12-14, 2026. CEO Steve Fife and CFO Carl Aure will present at approximately 1:00 p.m. ET on Monday, January 12, 2026. A live webcast of the presentation will be available on the company's Investor Relations News & Events page.
This provides investors and analysts access to company leadership commentary and a webcast replay option for those unable to attend live.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, LFVN gained 0.48%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peers show mixed moves: HAIN +6.73%, BHST +3.84%, FTLF +0.77% versus BRCC -4.39% and BYND -0.20%, suggesting stock-specific factors rather than a unified sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 10 | Investor presentation | Neutral | +1.2% | Announcement of CEO and CFO participation in Water Tower Fireside Chat. |
| Nov 12 | Clinical/product data | Positive | +0.9% | In vitro P84 data showing strong changes in multiple gut peptides and proteins. |
| Nov 04 | Dividend declaration | Positive | -4.6% | Board approval of a quarterly cash dividend of <b>$0.045</b> per share. |
| Nov 04 | Earnings results | Positive | -4.6% | Q1 FY26 results with revenue <b>$47.6M</b> and reiterated full-year guidance. |
| Oct 28 | Corporate event | Neutral | -0.2% | Momentum Academy 2025 event integrating LoveBiome and launching new products. |
Recent news (events, studies, investor presentations) has usually produced modest single-day moves, while financial items like earnings and dividend declarations have coincided with sharper downside reactions.
Over the last few months, LifeVantage reported Q1 fiscal 2026 results on Nov 4, 2025, including $47.6M revenue, positive net income, adjusted EBITDA, and reiterated fiscal 2026 guidance, yet the stock fell about 4.63%. A concurrent dividend declaration of $0.045 per share saw a similar decline. Earlier, the company highlighted its LoveBiome integration and product launches at Momentum Academy 2025 and released encouraging P84 gut health data with strong biomarker changes, both met with relatively small price moves. Another recent investor event (Water Tower Fireside Chat) also produced only a mild reaction.
Market Pulse Summary
This announcement highlights LifeVantage management’s participation in the 28th Annual ICR Conference from January 12–14, 2026, with a presentation at 1:00 p.m. Eastern on January 12. It follows recent milestones including Q1 fiscal 2026 results with $47.6M revenue, reiterated full-year guidance, and prior investor outreach via a Water Tower Fireside Chat. Investors may monitor any new commentary from the ICR presentation alongside ongoing integration of LoveBiome products and prior P84 gut health data updates.
Key Terms
nasdaq financial
AI-generated analysis. Not financial advice.
SALT LAKE CITY, Jan. 06, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer, and Carl Aure, Chief Financial Officer, will participate in the 28th Annual ICR Conference to be held January 12-14, 2026 in Orlando, FL.
Mr. Fife and Mr. Aure will present at approximately 1:00 p.m. Eastern Time on Monday, January 12, 2026. A webcast of their presentation will be accessible on the News & Events section of the Company’s Investor Relations website at https://lifevantage.gcs-web.com/ or directly here.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, MindBody GLP-1 System™, and the comprehensive gut activator, P84. The robust portfolio also includes activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com
FAQ
When will LifeVantage (LFVN) present at the 28th Annual ICR Conference?
Who from LifeVantage (LFVN) will speak at the ICR Conference on January 12, 2026?
How can investors watch LifeVantage's (LFVN) ICR Conference presentation?
What are the dates of the 28th Annual ICR Conference where LifeVantage (LFVN) will participate?
Will there be a replay available for LifeVantage's (LFVN) ICR presentation?
